Patients deteriorating from minimal cognitive impairment status to AD have elevated levels of astrocyte-derived exosomes containing factors of both classical and alternative complement pathways, including C1q, C4b, C5b, C3b, C5b–C9, and factor D [87]. Here, C5 is linked to Alzheimer disease.